entertainment -WSS

entertainment

author：Wikipedia 2025-10-01 12:35:27 - browse：7

STAT@ASCO 2024 — Chris Boshoff, far right, speaking at a panel with, from left, Matthew Herper of STAT, Ken Keller, Levi Garraway, and Susan Galbraith. Megan Bearder Photography

CHICAGO — The ways clinicians can treat cancers effectively are expanding, partly because technologies today are making old ideas possible, said a panel of oncology industry leaders at STAT@ASCO, STAT’s event here at the annual American Society of Clinical Oncology meeting.

“We’re seeing this expansion in modalities. We have more types of modalities that have arrived or arriving that allow us to exploit targets we’ve known about more than ever before. It’s very exciting,” said Levi Garraway, the chief medical officer of Genentech, at the event. “Things we’ve known about for a long time can be drugged for the first time or in a new, different way.”

That’s led to a surge of new medicines ranging from small molecules to cell therapies, with the potential uses of these treatments expanding into earlier lines of therapy and more cancer types each year. One example the panel singled out is the drug Enhertu, which recently received a tumor-agnostic approval from the Food and Drug Administration.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the pharma industry — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： What does generative AI mean for health care? We asked experts
Next article： Stanford president to resign after investigation of research

WSS

Ebola public health emergency is over, WHO declares

Stanford president to resign after investigation of research

'Reaching a detente': STAT's Helen Branswell on covering Covid

Readout LOUD podcast: Biotech layoffs, stock slump, 2024 preview

Why the Crimean Bridge is key to Russia's war in Ukraine

The tragedy of Johnson & Johnson’s Covid vaccine

explore

entertainment

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the pharma industry — by subscribing to STAT+.

Wikipedia

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Actors' union, Hollywood studios squabble over which side to blame as strike enters 5th day

Medicare proposal to cover medical devices draws a mixed reaction

Francis Collins on trust in science and how Covid communications failed

Activists slam private health insurers over coverage restrictions

Researchers separate signal from noise in heart wearable data

As demand for Covid shots wanes, Moderna seeks its next success

No Labels group has 'steep climb,' but third party 'worth trying': Larry Hogan

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Man who had jail sentence commuted by Trump arrested again

focus

Ebola public health emergency is over, WHO declares

Why some people catch Covid but never get sick

Researchers separate signal from noise in heart wearable data

eGenesis tests gene

Gilgo Beach murders: What questions remain following Rex Heuermann's arrest?

States increasingly look to regulate hospital facility fees

leisure time

hotspot

leisure time

focus